1Zlatescu MC, TehraniYazdi A, Sasaki H, et al. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res, 2001, 18: 6713-6715.
3Smith JS, Alderete B, Minn Y, et al. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene, 1999, 18:4144-4152.
4Zhu JJ, Santarius T, Wu X, et al. Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas. Genes Chromosomes Cancer, 1998, 21:207-216.
5Iuchi T, Namba H, Iwadate Y, et al. Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors. Genes Chromosomes Cancer, 2002, 35:170-175.
6Hashimoto N, Murakami M, Takahashi Y, et al. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p. Cancer, 2003, 97:2254
7Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendroliomas. J Natl Cancer Inst, 1998,90: 1473-1479.
8Hartmann C, Johnk L, Kitange G, et al. Transcript map of the 3.7 Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19. Cancer Res, 2002, 62: 4100-4108.
9Johnson MD, Wu X, Aithmitti N, et al. Peg3/Pw1 is a mediator between p53 and Bax in DNA damage-induced neuronal death. J Biol Chem, 2002, 277: 23000-23007.
10Fujisawa H, Marukawa K, Hasegawa M, et al. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors. J Neurosurg, 2002, 97:1350-1355.
二级参考文献10
1Fujimoto N, Fults DW, Thomas GA, et al. Loss of heterozygosity on chromosome 10 inhuman glioblastoma multiforme [J]. Genomics, 1989,4(2):210-124.
2Albarosa R, Colombo BM, Magnani I, et al. Deletion mapping of gliomas suggests thepresence of two small tegions for candidate tumour-supressor genes in a 17 cm interval onchromosome 10q[J]. Am J Hum Genet,1996,58(6): 1260-1267.
3Zhou XP, Li Y J, Khe HX, et al. Mutational analysis of the PTEN gene in glimoas:molecular and pathological correlations [ J ]. Int J Cancer, 1999,84(2): 150-154.
4Steck PA, Pershouse MA, Jasser SA,et al. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3that is mutated in multiple advanced cacers[J]. Nature Genetics, 1997, 15 (4):356-362.
5Smith JS, Tachibana I, Passe SM, et al. PTEN mutation, EGFR amplification, andoutcome in patients with anaplastic astrocytoma and glioblastoma multiforme[J]. J NatlCancer Inst,2001,15,93(16): 1246-1256.
6Duerr EM, Rollbrocker B, Hayashi Y, et al. PTEN mutations in gliomas andglioneuronal tumornal tumors [J]. Oncogene, 1998, 16 (17):2259-2264.
7Sasaki H, Zlatescu MC, Betensky RA, et al. PTEN is a target of chromosome 10q lossin anaplastic oligodendrogliomas and PTEN alterations are associated with poorprognosis[J]. Am J Pathol,2001,159(1):359-367.
8James CD, Carlblom E, Dumanski JP, et al. Clonal genomic alterations in gliomamalignancy stages[J]. Cancer Res, 1988,48(19) :5546-5551.
9Ransom DT, Ritland SR, Moertel CA, et al. Correlation of cytogenetic analysis andloss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas[J].Genes Chromosomes Cancer, 1992,5(4): 357-374.
10Maier D, Comparone D, Taylor E, et al. New deletion in low-grade oligodendrogliomaat the glioblastoma suppressor locus on chromosome 10q 25-26[J]. Oncogene,1997,15(8):997-1000.
9Kraus JA, Koopmann J, Kaskel P, et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol, 1995, 54: 91-95.
10von Deimling A, Fimmers R, Schmidt MC, et al. Comprehensive allelotype and genetic anaysis of 466 human nervous system tumors. J Neuropathol Exp Neurol, 2000, 59: 544-558.
